Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan HCTZ, 160/12.5mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC: 51655-950-52

D-1096-2018

July 18, 2018

Class II

Product summary

Firm
Northwind Pharmaceuticals LLC
Event
Event 80703
Status
Terminated
Classification
Class II
Quantity
43 bottles
Official record key
drug-enforcement:D-1096-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lot: UTB23790003, exp 02/28/2019

Distribution pattern: Indiana

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations